Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anthony C Gordon

Showing results (81-90 of 151) with videos related to

Pageof 16
Sort By:
JAMA|August 3, 2016
Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical TrialAnthony C Gordon, Alexina J Mason, Neeraja Thirunavukkarasu, et al.
Intensive Care Medicine Experimental|January 22, 2025
The effects of ultra-selective beta1-antagonism on the metabolic and cytokine profile in septic shock patients receiving noradrenaline: a sub-investigation from the STRESS-L Randomised StudyJarrod L Thomas, Kirsty C McGee, Anower Hossain, et al.
Critical Care Medicine|February 25, 2009
Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shockJames A Russell, Keith R Walley, Anthony C Gordon, et al.
Intensive Care Medicine|August 21, 2019
Levosimendan in septic shock in patients with biochemical evidence of cardiac dysfunction: a subgroup analysis of the LeoPARDS randomised trialDavid B Antcliffe, Shalini Santhakumaran, Robert M L Orme, et al.
Intensive Care Medicine|October 21, 2009
The effects of vasopressin on acute kidney injury in septic shockAnthony C Gordon, James A Russell, Keith R Walley, et al.
The New England Journal of Medicine|February 29, 2008
Vasopressin versus norepinephrine infusion in patients with septic shockJames A Russell, Keith R Walley, Joel Singer, et al.
Plos One|July 8, 2022
Association between tocilizumab, sarilumab and all-cause mortality at 28 days in hospitalised patients with COVID-19: A network meta-analysisPeter J Godolphin, David J Fisher, Lindsay R Berry, et al.
Transplantation|March 19, 2024
Developing Guidance for Donor Intervention Randomized Controlled Trials: Initial Discussions From the Canada-United Kingdom 2022 WorkshopMarat Slessarev, Katie L Bain, John Basmaji, et al.
JAMA|February 13, 2020
Effect of Reduced Exposure to Vasopressors on 90-Day Mortality in Older Critically Ill Patients With Vasodilatory Hypotension: A Randomized Clinical TrialFrançois Lamontagne, Alvin Richards-Belle, Karen Thomas, et al.
The Lancet. Respiratory Medicine|August 31, 2020
Prevalence of phenotypes of acute respiratory distress syndrome in critically ill patients with COVID-19: a prospective observational studyPratik Sinha, Carolyn S Calfee, Shiney Cherian, et al.
Pageof 16

Showing results (81-90 of 151) with videos related to

Sort By:
Pageof 16
JAMA|August 3, 2016
Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical TrialAnthony C Gordon, Alexina J Mason, Neeraja Thirunavukkarasu, et al.
Intensive Care Medicine Experimental|January 22, 2025
The effects of ultra-selective beta1-antagonism on the metabolic and cytokine profile in septic shock patients receiving noradrenaline: a sub-investigation from the STRESS-L Randomised StudyJarrod L Thomas, Kirsty C McGee, Anower Hossain, et al.
Critical Care Medicine|February 25, 2009
Interaction of vasopressin infusion, corticosteroid treatment, and mortality of septic shockJames A Russell, Keith R Walley, Anthony C Gordon, et al.
Intensive Care Medicine|August 21, 2019
Levosimendan in septic shock in patients with biochemical evidence of cardiac dysfunction: a subgroup analysis of the LeoPARDS randomised trialDavid B Antcliffe, Shalini Santhakumaran, Robert M L Orme, et al.
Intensive Care Medicine|October 21, 2009
The effects of vasopressin on acute kidney injury in septic shockAnthony C Gordon, James A Russell, Keith R Walley, et al.
The New England Journal of Medicine|February 29, 2008
Vasopressin versus norepinephrine infusion in patients with septic shockJames A Russell, Keith R Walley, Joel Singer, et al.
Plos One|July 8, 2022
Association between tocilizumab, sarilumab and all-cause mortality at 28 days in hospitalised patients with COVID-19: A network meta-analysisPeter J Godolphin, David J Fisher, Lindsay R Berry, et al.
Transplantation|March 19, 2024
Developing Guidance for Donor Intervention Randomized Controlled Trials: Initial Discussions From the Canada-United Kingdom 2022 WorkshopMarat Slessarev, Katie L Bain, John Basmaji, et al.
JAMA|February 13, 2020
Effect of Reduced Exposure to Vasopressors on 90-Day Mortality in Older Critically Ill Patients With Vasodilatory Hypotension: A Randomized Clinical TrialFrançois Lamontagne, Alvin Richards-Belle, Karen Thomas, et al.
The Lancet. Respiratory Medicine|August 31, 2020
Prevalence of phenotypes of acute respiratory distress syndrome in critically ill patients with COVID-19: a prospective observational studyPratik Sinha, Carolyn S Calfee, Shiney Cherian, et al.
Pageof 16